Home/Filings/4/0001450324-19-000003
4//SEC Filing

PASCALE ADAM 4

Accession 0001450324-19-000003

CIK 0000946644other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 10:59 AM ET

Size

5.2 KB

Accession

0001450324-19-000003

Insider Transaction Report

Form 4
Period: 2019-01-28
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2019-01-28+142,046142,046 total
    Exercise: $0.22From: 2019-01-28Exp: 2029-01-28Common Stock (142,046 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management for a voluntary 50% deferral in salary.

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeother

Related Parties

1
  • filerCIK 0001613377

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 10:59 AM ET
Size
5.2 KB